Integrative multi-omics landscape and diagnostic-therapeutic modelling of steatohepatitic hepatocellular carcinoma.

Multi-omics analysis identifies a lipid-rich, immune-infiltrated subtype of steatohepatitic hepatocellular carcinoma with an AUC of 0.909 for diagnosis.

• Why it matters: Understanding the molecular features of SH-HCC is crucial for developing accurate diagnostics and effective treatments, as current strategies are limited and poorly defined.
• What they did: Researchers integrated clinical and multi-omics data from 156 patients, creating diagnostic models based on lipid species and serum proteins, and validated FABP4 as a therapeutic target through mouse models.
• The result: The study established reliable diagnostic tools and revealed FABP4 as a promising target, with its inhibition suppressing tumor growth and improving immune response, paving the way for tailored therapies.